Skip to main content
. 2018 Jun 21;7(8):4132–4145. doi: 10.1002/cam4.1620

Figure 3.

Figure 3

Overall survival (OS) from diagnosis and time to progression (TTP) for IMWG and R‐ISS stages (patients without ASCT; N = 374)